These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 2869616)

  • 1. Oxprenolol in myocardial infarction survivors: brief review of the European Infarction Study results in the light of other beta-blocker post infarction trials.
    Schröder R
    Z Kardiol; 1985; 74 Suppl 6():165-72. PubMed ID: 2869616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. European Infarction Study (E.I.S.). A secondary prevention study with slow release oxprenolol after myocardial infarction: morbidity and mortality.
    Eur Heart J; 1984 Mar; 5(3):189-202. PubMed ID: 6373264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A long-term prevention study with oxprenolol in coronary heart disease.
    Taylor SH; Silke B; Ebbutt A; Sutton GC; Prout BJ; Burley DM
    N Engl J Med; 1982 Nov; 307(21):1293-301. PubMed ID: 6752712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta blockade after myocardial infarction: the Norwegian propranolol study in high-risk patients.
    Hansteen V
    Circulation; 1983 Jun; 67(6 Pt 2):I57-60. PubMed ID: 6342841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Beta-blocker Heart Attack Trial.
    Furberg CD
    Z Kardiol; 1985; 74 Suppl 6():159-63. PubMed ID: 2869615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter study on timolol in secondary prevention after myocardial infarction.
    Acta Med Scand Suppl; 1983; 674():1-129. PubMed ID: 6580807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockers in the secondary prevention of myocardial infarction: a review of clinical trials of 12 months or more duration.
    Decorde P
    Pharmatherapeutica; 1984; 3(8):515-25. PubMed ID: 6142464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stratification of arrhythmia risk and therapeutic options in survivors of acute myocardial infarction].
    Arós Borau F; Loma-Osorio A; Torres Bosco A
    Rev Esp Cardiol; 1996 Mar; 49(3):157-65. PubMed ID: 8685518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenergic blockade for survivors of acute myocardial infarction.
    Frishman WH; Furberg CD; Friedewald WT
    N Engl J Med; 1984 Mar; 310(13):830-7. PubMed ID: 6142420
    [No Abstract]   [Full Text] [Related]  

  • 10. Survival, myocardial infarction, and employment status in a prospective randomized study of coronary bypass surgery.
    Varnauskas E
    Circulation; 1985 Dec; 72(6 Pt 2):V90-101. PubMed ID: 3905064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Lopressor Intervention Trial: multicentre study of metoprolol in survivors of acute myocardial infarction. Lopressor Intervention Trial Research Group.
    Eur Heart J; 1987 Oct; 8(10):1056-64. PubMed ID: 2890522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European infarction study (EIS). A secondary prevention study with slow release oxprenolol after myocardial infarction.
    Eur Heart J; 1982 Dec; 3(6):583-6. PubMed ID: 6761123
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice.
    Viskin S; Kitzis I; Lev E; Zak Z; Heller K; Villa Y; Zajarias A; Laniado S; Belhassen B
    J Am Coll Cardiol; 1995 May; 25(6):1327-32. PubMed ID: 7722129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent.
    Stone JG; Foëx P; Sear JW; Johnson LL; Khambatta HJ; Triner L
    Anesthesiology; 1988 Apr; 68(4):495-500. PubMed ID: 2895596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-year follow-up of the Norwegian Multicenter Study on Timolol after Acute Myocardial Infarction.
    Pedersen TR
    N Engl J Med; 1985 Oct; 313(17):1055-8. PubMed ID: 2864634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial.
    Goldstein S
    Circulation; 1983 Jun; 67(6 Pt 2):I53-7. PubMed ID: 6342840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of oxprenolol on ventricular arrhythmias: the European Infarction Study experience.
    Bethge KP; Andresen D; Boissel JP; von Leitner ER; Peyrieux JC; Schröder R; Tietze U
    J Am Coll Cardiol; 1985 Nov; 6(5):963-72. PubMed ID: 2413097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non arrhythmogenic sudden death as complication of coronary heart disease].
    Zilcher H; Glogar D
    Acta Med Austriaca; 1979; 6(2):59-66. PubMed ID: 42254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Norwegian Multicenter Study of Timolol after Myocardial Infarction.
    Pedersen TR
    Circulation; 1983 Jun; 67(6 Pt 2):I49-53. PubMed ID: 6342838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.